NCT02392858 - Severe Influenza Cohort | Biotech Hunter

Enrollment

227

Participants

Timeline

Start Date

January 16, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions

InfluenzaSevere Respiratory Infection

Interventions

OTHER

influenza cohort

Influenza is a major cause of morbidity and mortality. The investigators' first goal is to evaluate soluble HLA-G5 isoform serum level as a potential marker of greater risk of death from Influenza respiratory illness in adult and pediatric patients hospitalized in reanimation. Secondly, the investigators collected respiratory samples in order to study the transcriptomic profiles of influenza-infected patients with severe symptoms.

Trial Locations (15)

69500

Centre de Biologie et de Pathologie Nord, Lyon

Unknown

Hôpital Femme Mère Enfant, Bron

CHU service réanimation adulte, Clermont-Ferrand

CHU service réanimation pédiatrique, Clermont-Ferrand

CHU service réanimation adulte, Dijon

CHU service réanimation pédiatrique, Dijon

CHU service réanimation adulte, Grenoble

CHU service réanimation pédiatrique, Grenoble

Centre de Biologie et Pathologie Est, Lyon

Hôpital de la Croix Rousse-service réanimation adulte chirurgicale, Lyon

Hôpital de la Croix Rousse-service réanimation adulte médicale, Lyon

Hôpital Edouard Herriot, Lyon

Centre Hospitalier Lyon Sud, Pierre-Bénite

CHU Service de Réanimation Adulte, Saint-Etienne

CHU Service de Réanimation Pédiatrique, Saint-Etienne

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER